National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials (PDQ®)
Patient Version   Health Professional Version
Last Modified: 1/6/2009     First Published: 4/23/2004  
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
Related Links
Educational Materials About Clinical Trials

Clinical Trials: Questions and Answers

Questions to Ask Your Doctor

Drug Information from MedlinePlus
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Related Information
Registry Information

Alternate Title

Phase III Randomized Study of Exemestane in Postmenopausal Women at Increased Risk of Developing Breast Cancer

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Prevention


Active


35 and over


Other, Pharmaceutical / Industry


CAN-NCIC-MAP3
PFIZER-EXEAPO-0028-150, ExCel, NCT00083174, MAP3

Trial Description

Purpose:

Hormone therapy using exemestane may fight breast cancer by reducing the production of estrogen and progesterone.

This randomized phase III trial is studying exemestane to see how well it works in preventing cancer in postmenopausal women who are at increased risk of developing breast cancer.

Eligibility:

Eligibility criteria include the following:

  • At least 35 years old
  • No previous invasive breast cancer
  • More than 3 months since hormone therapy
  • For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will be randomly assigned to one of two groups.

Patients in group one will receive exemestane by mouth once a day for 5 years.

Patients in group two will receive placebo by mouth once a day for 5 years.

Quality of life will be assessed periodically. Patients will be evaluated every 6 months for 1 year and once a year thereafter.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NCIC-Clinical Trials Group

Paul Goss, MD, PhD, Protocol chair
Ph: 617-724-3118; 877-726-5130

Trial Sites

U.S.A.
Alabama
  Birmingham
 Jefferson Clinic, PC
 Rowell S. Ashford II
Ph: 205-279-2867
 Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
 Clinical Trials Office - Lurleen Wallace Comprehensive Cancer
Ph: 205-934-0309
Alaska
  Anchorage
 Providence Cancer Center
 Clinical Trials Office - Providence Cancer Center
Ph: 907-261-3109
California
  Duarte
 City of Hope Comprehensive Cancer Center
 Clinical Trials Office - City of Hope Comprehensive Cancer Center
Ph: 800-826-4673
 Email: becomingapatient@coh.org
  Mission Viego
 Mission Cancer Center at Mission Hospital
 Lisa D. Curcio
Ph: 949-770-0797
  Sacramento
 University of California Davis Cancer Center
 Clinical Trials Office - University of California Davis Cancer Center
Ph: 916-734-3089
  San Francisco
 UCSF Helen Diller Family Comprehensive Cancer Center
 Clinical Trials Office - UCSF Helen Diller Family Comprehensive Cancer Center
Ph: 877-827-3222
  Torrance
 Los Angeles Biomedical Research Institute
 Rowan Chlebowski
Ph: 310-222-2217
Colorado
  Aurora
 University of Colorado Cancer Center at UC Health Sciences Center
 Clinical Trials Office - University of Colorado Cancer Center
Ph: 720-848-0650
Connecticut
  Farmington
 Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
 Clinical Trials Office - Carole and Ray Neag Comprehensive Cancer Center
Ph: 800-579-7822
  Norwalk
 Norwalk Hospital
 Richard C. Frank
Ph: 203-845-2132
District of Columbia
  Washington
 George Washington University Medical Center
 Clinical Trials Office - George Washington University Medical Center
Ph: 202-741-2981
 MedStar Research Institute
 Clinical Trials Office - MedStar Research Institute
Ph: 202-787-5710
Florida
  Jacksonville
 Mayo Clinic - Jacksonville
 Clinical Trials Office - All Mayo Clinic Locations
Ph: 507-538-7623
  Miami
 University of Miami Sylvester Comprehensive Cancer Center - Miami
 University of Miami Sylvester Comprehensive Cancer Center Clinical Trial Matching Service
Ph: 866-574-5124
 Email: Sylvester@emergingmed.com
Georgia
  Tucker
 Georgia Cancer Specialists - Tucker
 Mansoor Saleh
Ph: 404-256-4777
Illinois
  Chicago
 John H. Stroger, Jr. Hospital of Cook County
 Pamela S. Ganschow
Ph: 312-864-4436
 Mercy Hospital and Medical Center
 Alejandra Perez-Tamayo
Ph: 312-567-5469
 University of Chicago Cancer Research Center
 Clinical Trials Office - University of Chicago Cancer Research Center
Ph: 773-834-7424
  Maywood
 Cardinal Bernardin Cancer Center at Loyola University Medical Center
 Clinical Trials Office - Cardinal Bernardin Cancer Center
Ph: 708-226-4357
  Moline
 Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
 Costas L. Constantinou
Ph: 563-779-5059
  Normal
 Mid-Illinois Hematology-Oncology Associates at Community Cancer Center
 John Migas
Ph: 309-452-9701
  Urbana
 CCOP - Carle Cancer Center
 Clinical Trials Office - CCOP - Carle Cancer Center
Ph: 800-446-5532
Indiana
  Indianapolis
 Indiana University Melvin and Bren Simon Cancer Center
 Clinical Trials Office - Indiana University Cancer Center
Ph: 317-274-2552
Kansas
  Kansas City
 Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
 Clinical Trials Office - Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Ph: 913-588-4709
Maine
  Scarborough
 Maine Center for Cancer Medicine and Blood Disorders - Scarborough
 Tracey F. Weisberg
Ph: 207-885-7600
Maryland
  Bethesda
 Suburban Hospital Cancer Program
 Carolyn Hendricks
Ph: 301-897-1503
Massachusetts
  Boston
 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
 Judy E. Garber
Ph: 617-632-3800
 Massachusetts General Hospital
 Clinical Trials Office - Massachusetts General Hospital
Ph: 877-726-5130
Michigan
  Detroit
 Hutzel Hospital
 Susan Hendrix
Ph: 313-745-0499
  Royal Oak
 William Beaumont Hospital - Royal Oak Campus
 Clinical Trials Office - William Beaumont Hospital - Royal Oak Campus
Ph: 248-551-7695
Minnesota
  Rochester
 Mayo Clinic Cancer Center
 Clinical Trials Office - All Mayo Clinic Locations
Ph: 507-538-7623
Missouri
  St. Louis
 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
 Antonella Rastelli
Ph: 314-454-8017
New Jersey
  New Brunswick
 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
 Clinical Trials Office - Cancer Institute of New Jersey
Ph: 732-235-8675
New York
  Bronx
 Albert Einstein Cancer Center at Albert Einstein College of Medicine
 Clinical Trials Office - Albert Einstein Cancer Center at Albert Einstein College of Medicine
Ph: 718-904-2730
 Email: aecc@aecom.yu.edu
  Buffalo
 Roswell Park Cancer Institute
 Clinical Trials Office - Roswell Park Cancer Institute
Ph: 877-275-7724
North Carolina
  Kinston
 Kinston Medical Specialists
 Mishab U. Qadir
Ph: 252-559-2201
Ohio
  Cincinnati
 Charles M. Barrett Cancer Center at University Hospital
 Kathleen A. Havlin
Ph: 514-584-6178
Oklahoma
  Oklahoma City
 Oklahoma University Cancer Institute
 William C. Dooley
Ph: 405-271-7867
Pennsylvania
  Philadelphia
 Abramson Cancer Center of the University of Pennsylvania
 Clinical Trials Office - Abramson Cancer Center of the University of Pennsylvania
Ph: 800-474-9892
Rhode Island
  Pawtucket
 Memorial Hospital of Rhode Island
 Michele Cyr
Ph: 401-444-8537
Tennessee
  Memphis
 University of Tennessee College of Medicine
 Clinical Trials Office - University of Tennessee College of Medicine
Ph: 901-516-2212
Vermont
  Burlington
 Fletcher Allen Health Care - University Health Center Campus
 Clinical Trials Office - Fletcher Allen Health Care
Ph: 802-656-8990
Washington
  Seattle
 Fred Hutchinson Cancer Research Center
 Anne McTiernan
Ph: 206-667-6196
Wisconsin
  Madison
 University of Wisconsin Center for Women's Health Research
 Gloria E. Sarto
Ph: 608-267-5572
  Milwaukee
 Medical College of Wisconsin Cancer Center
 Clinical Trials Office - Medical College of Wisconsin Cancer Center
Ph: 414-805-4380
Canada
British Columbia
  Kelowna
 British Columbia Cancer Agency - Centre for the Southern Interior
 Susan Ellard
Ph: 250-712-3922
  Vancouver
 British Columbia Cancer Agency - Vancouver Cancer Centre
 Karen Gelmon
Ph: 604-877-6000
Manitoba
  Winnipeg
 CancerCare Manitoba
 Andrew L. Cooke
Ph: 204-787-1458
New Brunswick
  Saint John
 Saint John Regional Hospital
 Hugh M.C. Scarth
Ph: 506-648-7921
Ontario
  Hamilton
 Margaret and Charles Juravinski Cancer Centre
 James R. Wright
Ph: 905-387-9495
  Kingston
 Cancer Centre of Southeastern Ontario at Kingston General Hospital
 Conrad Falkson
Ph: 613-544-2631
  London
 London Regional Cancer Program at London Health Sciences Centre
 Eric W. Winquist
Ph: 519-685-8640
  Ottawa
 Meadowlands Family Health Center
 Barry Dworkin
Ph: 613-228-2882
 Ottawa Hospital Regional Cancer Centre - General Campus
 Shailendra Verma
Ph: 613-737-7700
  Sault Ste. Marie
 Algoma District Cancer Program at Sault Area Hospital
 Silvana Spadafora
Ph: 705-759-3434
  Sudbury
 Northeastern Ontario Regional Cancer Centre
 Amanda Hey
Ph: 705-522-6237
  Toronto
 Edmond Odette Cancer Centre at Sunnybrook
 Kathleen I. Pritchard
Ph: 416-480-4616
 Mount Sinai Hospital - Toronto
 Louise Bordeleau
Ph: 416-586-3202
 New Women's College Hospital
 Lavina Lickley
Ph: 416-323-6120
 Princess Margaret Hospital
 Angela M. Cheung
Ph: 416-340-4301
 Toronto East General Hospital
 Yasmin H. Rahim
Ph: 416-469-3325
Quebec
  Montreal
 CHUM - Hopital Saint-Luc
 Marie-Helen Mayrand
Ph: 514-890-8000
 Hopital Notre-Dame du CHUM
 Edgard Nassif
Ph: 514-890-8000
 Maisonneuve-Rosemont Hospital
 Pierre Dube
Ph: 514-252-3822
  Quebec City
 Hopital du Saint-Sacrement - Quebec
 Louise Provencher
Ph: 418-682-7511
Puerto Rico
  Orocovis
 Orocovis Medical Center
 Jose Sabino Aponte Pagan
Ph: 787-867-0272
  San Juan
 Altamira Family and Prevention Clinic
 Jamie Claudio
Ph: 787-792-9026

Related Information

Web site for additional information

Registry Information
Official Title A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Trial Start Date 2004-02-11
Trial Completion Date 2010-06-01 (estimated)
Registered in ClinicalTrials.gov NCT00083174
Date Submitted to PDQ 2004-03-25
Information Last Verified 2009-01-11

Back to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov